Primer: uniQure NV (QURE US) - Sep 2025
uniQure is a pioneering gene therapy company with one approved product, HEMGENIX®, for Hemophilia B, which is the first and only gene therapy...
309 Views
𝛼SK or SearchENTITY
uniQure NV (QURE US)
uniQure NV (QURE US)
16
Analysis
Health Care • Netherlands
uniQure N.V. delivers gene therapy with single treatments for curative results. The Company develops a modular platform to bring new disease modifying therapies to patients with severe genetic diseases, as well as offers ongoing clinical programs in hemophilia B and pre-clinical proof-of-concept in Huntington's disease.
morex